diethylnitrosamine has been researched along with Diabetes Mellitus, Type 2 in 3 studies
Diethylnitrosamine: A nitrosamine derivative with alkylating, carcinogenic, and mutagenic properties.
N-nitrosodiethylamine : A nitrosamine that is N-ethylethanamine substituted by a nitroso group at the N-atom.
Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "ET in the prevention of liver cancer is poorly understood." | 5.56 | Endurance training but not high-intensity interval training reduces liver carcinogenesis in mice with hepatocellular carcinogen diethylnitrosamine. ( Cao, L; Ding, S; Ji, B; Li, L; Qi, Z; Zhang, X, 2020) |
| "ET in the prevention of liver cancer is poorly understood." | 1.56 | Endurance training but not high-intensity interval training reduces liver carcinogenesis in mice with hepatocellular carcinogen diethylnitrosamine. ( Cao, L; Ding, S; Ji, B; Li, L; Qi, Z; Zhang, X, 2020) |
| "The current epidemics of type 2 diabetes mellitus (T2DM), non-alcoholic steatohepatitis (NASH), and Alzheimer's disease (AD) all represent insulin-resistance diseases." | 1.35 | Nitrosamine exposure causes insulin resistance diseases: relevance to type 2 diabetes mellitus, non-alcoholic steatohepatitis, and Alzheimer's disease. ( de la Monte, SM; Lawton, M; Longato, L; Neusner, A; Tong, M; Wands, JR, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Li, K | 1 |
| Ricker, K | 1 |
| Tsai, FC | 1 |
| Hsieh, CJ | 1 |
| Osborne, G | 1 |
| Sun, M | 1 |
| Marder, ME | 1 |
| Elmore, S | 1 |
| Schmitz, R | 1 |
| Sandy, MS | 1 |
| Zhang, X | 1 |
| Cao, L | 1 |
| Ji, B | 1 |
| Li, L | 1 |
| Qi, Z | 1 |
| Ding, S | 1 |
| Tong, M | 1 |
| Neusner, A | 1 |
| Longato, L | 1 |
| Lawton, M | 1 |
| Wands, JR | 1 |
| de la Monte, SM | 1 |
3 other studies available for diethylnitrosamine and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Estimated Cancer Risks Associated with Nitrosamine Contamination in Commonly Used Medications.
Topics: Animals; Carcinogens; Diabetes Mellitus, Type 2; Diethylnitrosamine; Dimethylnitrosamine; Neoplasms; | 2021 |
Endurance training but not high-intensity interval training reduces liver carcinogenesis in mice with hepatocellular carcinogen diethylnitrosamine.
Topics: Animals; Carcinogenesis; Carcinogens; Carcinoma, Hepatocellular; Diabetes Mellitus, Type 2; Diethyln | 2020 |
Nitrosamine exposure causes insulin resistance diseases: relevance to type 2 diabetes mellitus, non-alcoholic steatohepatitis, and Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Animals, Newborn; | 2009 |